The protection quest is a primary key to sharing the neutralizing antibody response to cover against all emerging VOCs based on BIV1-CovIran studies
Over time, the antigenic evolution of emerging variants of SARS-CoV-2 has demanded the development of potential protective vaccines. Administration of additional doses of current vaccines based on the WT spike protein may boost immunity, but their effectiveness has dwindled for patients with more re...
Main Authors: | Maryam Shafaati, Kowsar Bagherzadeh, Majid Lotfinia, Hesam Karimi, Ali Teimoori, Mehdi Razazian, Sepideh Meidaninikjeh, Hamed Hosseini, Hamid Reza Jamshidi, Hasan Jalili, Asghar Abdoli |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023013154 |
Similar Items
-
Study on erythropoiesis-, leukopoiesis- and thrombocytopoiesis – stimulating activity of compounds BIV-241, BIV-242, BIV-243
by: Sokolenko Anastassiya, et al.
Published: (2024-01-01) -
Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection
by: Sergey V. Kulemzin, et al.
Published: (2024-01-01) -
Homologous or Heterologous COVID-19 Booster Regimens Significantly Impact Sero-Neutralization of SARS-CoV-2 Virus and Its Variants
by: Rome Buathong, et al.
Published: (2022-08-01) -
Characterization of the Antibody and Interferon-Gamma Release Response after a Second COVID-19 Booster Vaccination
by: Katharina Grikscheit, et al.
Published: (2022-07-01) -
Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients
by: Claudia Maria Trombetta, et al.
Published: (2021-07-01)